THE DEFINITION OF REFRACTORINESS TO PLATELET TRANSFUSIONS

被引:60
作者
BISHOP, JF
MATTHEWS, JP
YUEN, K
MCGRATH, K
WOLF, MM
SZER, J
机构
[1] ALFRED HOSP, PETER MACCALLUM CANC INST, MELBOURNE, AUSTRALIA
[2] RED CROSS BLOOD BANK, MELBOURNE, AUSTRALIA
关键词
PLATELET; REFRACTORINESS; TRANSFUSION;
D O I
10.1111/j.1365-3148.1992.tb00132.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between the 1 and 20 h post-transfusion platelet count and three parameters used to define refractory transfusions, namely the corrected increment (CI), platelet increment (PI), and percentage platelet recovery (%REC), was studied in 437 non-HLA matched platelet transfusions given to 102 patients with bone marrow failure, The percentage agreement between common definitions of refractoriness was calculated based on these parameters. As the maintenance of platelet counts above 20 x 10(9)/l is a relevant clinical goal for platelet support, the values of the CI, PI a nd %REC, which best co responded to 1- and 20-h post-transfusion counts of 20 x 10(9)/l, were identified. A 1-h post-transfusion CI < 3 (PI < 7 x 10(9)/l or % REC <8%) corresponded to clinically unsuccessful transfusions with a 1-h platelet count < 20 x 10(9)/l. A 1-h CI greater-than-or-equal-to 5.5 (PI greater-than-or-equal-to 10(9)/l or %REC greater-than-or-equal-to 14%) corresponded to clinically successful transfusions with a 20-h post-transfusion count of greater-than-or-equal-to 20 x 10/l. These data tie together the end points reported in the literature for defining refractory transfusions.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 30 条
[1]  
AISNER J, 1980, CLIN MED, P1
[2]   THE EFFECTS OF SPLENECTOMY ON ENGRAFTMENT AND PLATELET TRANSFUSION REQUIREMENTS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA UNDERGOING MARROW TRANSPLANTATION [J].
BANAJI, M ;
BEARMAN, SI ;
BUCKNER, CD ;
CLIFT, RA ;
BENSINGER, WI ;
PETERSEN, FB ;
SLICHTER, SJ ;
MCGUFFIN, RW ;
SANDERS, JE ;
STEWART, PS ;
HILL, RS ;
DEEG, HJ ;
STORB, R ;
THOMAS, ED .
AMERICAN JOURNAL OF HEMATOLOGY, 1986, 22 (03) :275-283
[3]   FACTORS INFLUENCING 20-HOUR INCREMENTS AFTER PLATELET TRANSFUSION [J].
BISHOP, JF ;
MATTHEWS, JP ;
MCGRATH, K ;
YUEN, K ;
WOLF, MM ;
SZER, J .
TRANSFUSION, 1991, 31 (05) :392-396
[4]  
BISHOP JF, 1988, BLOOD, V71, P383
[5]   PLATELET TRANSFUSION THERAPY - ONE-HOUR POST-TRANSFUSION INCREMENTS ARE VALUABLE IN PREDICTING THE NEED FOR HLA-MATCHED PREPARATIONS [J].
DALY, PA ;
SCHIFFER, CA ;
AISNER, J ;
WIERNIK, PH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (05) :435-438
[6]   PREDICTIVE VALUE OF CROSS-MATCHING FOR TRANSFUSION OF PLATELET CONCENTRATES TO ALLOIMMUNIZED RECIPIENTS [J].
FILIP, DJ ;
DUQUESNOY, RJ ;
ASTER, RH .
AMERICAN JOURNAL OF HEMATOLOGY, 1976, 1 (04) :471-479
[7]   EFFECTIVENESS OF PLATELET TRANSFUSION IN LEUKEMIA AND APLASTIC ANEMIA [J].
FREIREICH, EJ .
TRANSFUSION, 1966, 6 (01) :50-+
[8]   QUANTITATIVE RELATION BETWEEN PLATELET COUNT AND HEMORRHAGE IN PATIENTS WITH ACUTE LEUKEMIA [J].
GAYDOS, LA ;
MANTEL, N ;
FREIREICH, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1962, 266 (18) :905-&
[9]   NORMAL GRANULOCYTE TRANSFUSION THERAPY - TREATMENT OF SEPTICEMIA DUE TO GRAM-NEGATIVE BACTERIA [J].
GRAW, RG ;
PERRY, S ;
HERZIG, G ;
HENDERSON, ES .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (08) :367-+
[10]  
HAN T, 1966, CANCER, V19, P1937, DOI 10.1002/1097-0142(196612)19:12<1937::AID-CNCR2820191221>3.0.CO